Be a mentor, connect with mentors and discover new ways to advance your innovations.
The McMaster Entrepreneurship Academy hosts programs that enable entrepreneurs to connect with peer mentors, investors, advisors, and industry leaders to help them grow their businesses.
Through workshops, networking events and dedicated mentorship programs, entrepreneurs can build their networks, gain sector specific advice from leaders in their fields, attract external funding for their startups and explore new ways to innovate.
The McMaster Mentorship Network is a program geared towards supporting McMaster start-ups in attracting external funding, growing their business, and increasing their chances of success. The McMaster Entrepreneurship Academy and the Forge at McMaster, together with the McMaster Industry Liaison Office (MILO), is engaging experienced executives, investors and serial entrepreneurs interested in contributing their expertise and experience for advancing high-potential commercialization opportunities. The program will focus on providing mentorship to McMaster Entrepreneurship Academy participants, Forge supported companies, McMaster Seed Fund applicants, amongst others.
To learn more, please contact Leigh Wilson, Associate Director, New Ventures.
Greg is a 15-year go-to-market (GTM) veteran in the B2B SaaS space, and has spent the past 3 years building out and supporting the GTM motion for a B2C strategy as well. Greg’s experience includes being a quota carrying individual closing $1M ARR deals, growing a Customer Success program from scratch to $50M in ARR, and now, holding full Revenue accountability (Sales, Marketing, and CS) as a founding Executive team member. Greg has worked directly with Board of Directors, and participated in Series A and B fundraising processes as a Revenue executive.
Greg’s had deep experience in Edu-Tech, but has consulted with businesses in a variety of SaaS sectors.
Outside of SaaS/Tech, Greg grew up with a dad who is an entrepreneur and ran a successful retail operation for 30+ years. Much of what he applies in his business career today was what he learned working in all aspects of the family business from the age of 12…and ultimately, business comes down to working hard, and doing right by the people you impact: Customers, Suppliers, Team Members, and your community.
Don has over 30 years of experience in the regulation of medical devices in Canada. He was employed with Health Canada from 1982-2014. His experience includes compliance monitoring and enforcement; technical / scientific evaluation of high-risk medical devices; establishment licensing; interpretation of legislation and regulations; redesignign the Canadian Medical Devices Program including the drafting and implementation of the 1998 Medical Devices Regulations; and held senior management positions of national regulatory programs, including Director, Medical Devices Bureau. He is currently established as a consultant (BOYER@ReglulatorySolns) and can provide regulatory intelligence, strategy and solutions to industry clients. He has an HBSc from the University of Toronto and holds the Regulatory Affairs Professional Society (RAPS) Regulatory Affairs Certification (RAC), is a Fellow of RAPS (FRAP). In 2022 he received the Founder’s Award from RAPS which recognizes exemplary regulatory professionals shaping regulatory policy and practice, contributions to education and mentoring, and volunteering in leadership positions to advance the profession.
Andrew is an experienced physician leader who has extensive knowledge of hospital operations and healthcare analytics. He completed his MBA focusing on healthcare entrepreneurship and innovation, working with several venture capital firms to develop healthcare investing theses and leading diligence efforts on potential investment opportunities. Andrew is very excited about developments in digital health and medical technology and is open to assisting with entrepreneurial challenges that may arise.
Past Experience: Veterinary radiologist, contract research, preclinical and translational drug development, medical devices
How Howard can help you with your venture:Following an academic career at the University of Guelph, I have worked in contract research for the last 20 years. Now I work as a consultant with a number of established companies as well as start-ups. Most of my work has been in preclinical and translational aspects of drug development, but also with medical devices. This has involved multiple disease categories.
In this area of research, transitioning from a university-based laboratory to a start-up company often involves animal work outside of the university. My broad experience in selecting or developing animal models and study design, as well as finding the best contract research organization, can be an asset to any growing company.
While much of my career has involved imaging, including all imaging modalities across the full range of species, I am equally at home with non-imaging based work. I am closely involved with the newly established University of Guelph Bench to Bedside Institute for Translational Health Research, where one of my roles is business development, which includes engaging with start-up companies where a clinical trial in naturally occurring disease in companion animals can be a means to derisk a human clinical trial. I am also an active angel investor, having been a member of the Golden Triangle Angel Network (GTAN) for several years. As a result, I fully understand the issues associated with starting up a company.
I am available for discussions and greater engagement at any stage in the development of a new company. Please do not be put off by the fact that I am wearing a tie in my picture. I was brought up in the UK where it was mandatory to wear a tie from primary school through high school and for parts of a professional university programme. Instead of rebelling against ties, as many of my friends did, I grew to like them. Now a tie is part of my brand, I am the tie guy which makes me easy to remember.
Charmaine knew she wanted to be an accountant from the age of eight. What she didn’t know then was where that decision would take her.
Her career started in public accounting, where she built the technical foundation that still anchors how she thinks about business. She then moved into industry and learned how businesses actually operate from the shop floor through to the executive table. Over the course of her career, she has worked with companies through commercialization, rapid growth, transformation and increasing complexity, scaling businesses ranging from $80M to $500M across Canada, the U.S. and Mexico.
Her role has never been “just finance.” She operates where capital, operations, commercial strategy and leadership come together. She has spent much of her career helping leadership teams see the connections between those areas, break down silos and turn strategy into something the organization can actually execute.
One lesson has stayed with her: you don’t need to build everything at once. As a company grows, knowing when to add structure and when not to can be just as important as knowing what to build. Charmaine believes founders don’t need to become finance experts to build financially sound businesses. She takes complex business issues and makes them easy to understand for everyone around the table. She then turns that understanding into clear priorities and practical steps the business can act on.
Her mandate is simple: bring clarity, build discipline, and put the right foundation underneath the ambition. Secure the runway. Anchor the systems. Let growth breathe.
Over the last 20+ years, Darren has worked for a global med-tech company as Head of Finance, and then assumed the Sales leadership role on his way to becoming General Manager of the Canadian Division.
It is this broad and deep experience overseeing all company functions that makes him particularly well suited to help start-ups, not only with their finances, but with building their capabilities in the other functional areas as well. He has been involved in the spectrum of business processes from product concept, R&D, product messaging and launch, right through to market and customer support.
His key differentiator as a Fractional CFO is his experience of having been a business leader. He understands what information is critical to business leaders and his ability to function as their key financial partner helps lighten their load so they can focus squarely on building the business.
He is passionate about helping new companies establish a strong financial foundation and put together a comprehensive business plan of how they are going to be successful in the market. Working with startups, he helps build the financial and business models that anticipate future challenges so as to chart a successful trajectory for the venture.
Darren would love a chance to engage with you and hear how he may be able to help your company grow.
Paul Fitzgerald is the Founder and CEO of Salt & Pepper Media Inc., a well-known public relations firm based in Burlington, Hamilton, and Toronto. The firm also has field offices in Montreal, Calgary, Vancouver, New York City, Chicago, San Diego, Las Vegas, and Los Angeles.
He is also a columnist with Entrepreneur Magazine, and his work has frequently appeared in USA Today, CNN International Report, The Toronto Sun, and InventorSpot.com. He is also a new innovations and technology columnist with The Toronto Tribune, The Toronto Post-Gazette and The New York City Herald. Additionally, he hosts the top tech tip spotlight on Halton Outlook Today (HOT) News.
Fitzgerald’s firm works with start-ups of all sizes in Canada and the USA. CNN, FOX, ABC, CBS, NBC, The Globe & Mail, The Toronto Sun, CTV, Global, CBC, The New York Times, and The Los Angeles Times are just a handful of media outlets Salt & Pepper Media Inc. works with to help secure news coverage for its clients.
His media company offers a wide variety of services for start-ups and established ventures, which include Press Releases, Public Relations, Social Media, Website Design, Marketing, Communications, Branding, and Business Development.
Fitzgerald is also committed to giving back and is a staunch supported of community outreach with The Burlington Teen Tour Band Alumni, Arts For A Better Tomorrow (ABT) in Los Angeles, and It’s Okay Not To Be Okay in Canada.
He is nearing completion of his PhD in Communication Sciences and holds a Master of Arts (MA) Degree (Interdisciplinary Studies) in Journalism and Communications and a Bachelor of Arts (BA) from SMU. He is also a graduate of the Broadcast Journalism Program at Mohawk College of Applied Arts & Technology in Hamilton.
Neil Fleischer is an entrepreneur and commercialization strategist based in Montreal. As Founder of Zero21 Advisory, he works with university researchers, tech transfer offices, incubators, and accelerators to evaluate commercial viability, define go-to-market strategy, and prepare first-time founders for the realities of building a company. He serves as a Fractional Entrepreneur-in-Residence for research institutions looking to turn promising science into market-ready ventures.
Neil co-founded and led Cube AI, an emotion and attention AI company at the intersection of biometrics and artificial intelligence. He guided the company from concept to execution, building technology that used physiological data including EEG, heart rate, and pupilometry to measure and interpret human emotional and cognitive states in real time. He built and closed B2B enterprise sales with large organizations, giving him direct experience across the full arc from research-stage technology to commercial deployment.
In 2023, Neil was recognized as one of the ESOMAR Insights250 Global Leaders, an annual selection of the most influential people shaping the future of data, research, and insights worldwide.
Neil holds an MBA and is based in Montreal, Quebec.
Graeme Fraser is a pharmacologist with more than 20 years of operational experience to lead projects from basic research through to completion of clinical proof-of-concept. He has a particular interest to work with early-stage companies seeking to translate basic research discoveries into novel therapeutics. He can bring particular expertise in the space of small-molecule lead optimization, preclinical and early-clinical aspects of drug development, raising venture capital and scientific management of start-up biotech companies.
Currently, he is serving as Chief Scientific Officer of EPICS SA (Belgium), a biotech company focused on small-molecule drug discovery in the field of epigenetics for the treatment of cancer. Previously, Graeme was Chief Scientific Officer of OGEDA SA (Belgium) where he is an inventor of fezolinetant (Veozah™), a product since acquired by ASTELLAS and approved for market in 2023 in Women’s Health. In total, Graeme has led Drug Discovery activities at biotech and pharmaceutical companies in Canada and Europe in the fields of cancer, gastrointestinal disease, endocrinology and pain with 5 products advanced into clinical development. In the biotech space, he has been successful as part of the management team to successfully raise venture capital and ultimately reward investors with two successful exits.
Benjamin Garden, VP of Analytics at Iris Pricing Solutions in Toronto, brings over 15 years of experience in leveraging analytics and AI to drive business growth and profitability. With a rich background in team leadership across global markets and expertise in areas like pricing strategy, marketing analytics, SaaS solutions, and strategic planning, Benjamin combines technical proficiency with a passion for fostering innovation and organizational excellence. He is a member on the Board of Directors for THRIVEfunds, an anti-poverty Non-Profit organization. His commitment to professional development makes him a valuable mentor, ready to share his insights and experience in navigating complex business environments.
Bassma is a dynamic healthcare innovation executive, holding a PhD in Biomedical Engineering and distinguished as a serial entrepreneur driven by a fervent commitment to advancing innovative healthcare solutions. Dr. Ghali possesses a well-established expertise in research and development, leading diverse teams through the entire spectrum of product development in the medical technology and digital health arena, from proof of concept to successful product launch.
Her proficiency spans numerous clinical applications of biomedical engineering, encompassing areas such as medical device technologies, health monitoring, virtual care systems, machine learning (AI), and comprehensive data collection and analysis. Fueled by her entrepreneurial spirit, she has spearheaded the establishment and leadership of multiple health technology startups, focusing on the creation and launch of pioneering wearable medical devices and remote patient monitoring platforms, all in alignment with her vision of enhancing health outcomes. Throughout these ventures, Dr. Ghali has worn various hats, assuming roles in product management and development, team building and leadership, fundraising initiatives, as well as the establishment of processes and strategic partnerships.
Dr. Ghali’s academic background includes a Ph.D. in Biomedical Engineering from the University of Toronto, a M.A.Sc. from McMaster University, and a B.Eng. from Ryerson University
Petter Hansson is a strategic growth leader with 25 years of experience building, transforming, and scaling businesses from startups to large multinational organizations in Canada, the United States, and Europe. He has held multiple P&L-owning General Manager roles in MedTech, infection control, and healthcare services, leading turnarounds, market expansions, and post-acquisition transformations with revenues up to approximately 150M.
Known for his decisive and collaborative leadership style, he has driven double-digit growth, significant EBITDA expansion, and large public-sector contract wins through data-driven decision-making, stakeholder alignment, and a strong customer-centric focus.
Petter holds an Executive MBA from the Ivey Business School and today, through SGF Executive Group and Eliomedica, he advises executive teams and business leaders on commercialization, operational excellence, and growth strategy across North America and Globally.
He is passionate about helping companies build a strong foundation and build a strategic mindset that drives impact.
Kareem Hassanein is a practicing physiotherapist who advises health-tech and health innovation startups on clinical implementation, digital adoption, and the practical realities of bringing new tools into care delivery and service operations. He brings a McMaster background in kinesiology and graduate training in physiotherapy from Robert Gordon University, where he completed his MSc with Distinction.
His perspective is grounded in thousands of hours of direct coaching and patient care, along with clinic operations and practical experience introducing digital tools into clinical and professional settings. Kareem helps founders examine how their product fits into existing routines, what it asks of clinicians, patients, and teams, and how to adjust the design, workflow, or rollout so it has a better chance of becoming part of routine use.
His mentorship is especially relevant to startups developing rehabilitation, patient engagement, and clinical workflow tools, as well as teams navigating digital health implementation, AI adoption, and service innovation.
William has been teaching corporate finance, investments, management economics, and financial history for 15 years, first at the Rotman and now at DeGroote. He has some experience working with SMEs on financial modelling, working capital, valuation, and organizational design.
Bruce is a commercialization and market strategy advisor who works with researchers, founders, and early-stage ventures to assess market opportunity and define practical pathways to commercialization. His advisory work focuses on product-market fit, customer and stakeholder validation, market assessment, competitive analysis, and go-to-market planning.
He has supported numerous university-led and publicly funded innovation projects through his work with McMaster University, Innovation Factory and as a Senior Consultant with Foresight Science & Technology, including commercialization assessments for NIH, DOE, EPA, and NSERC-supported technologies. His sector experience spans life sciences, healthcare, diagnostics, environmental and clean technologies, agritech, energy, transportation, and software.
He brings over 25 years of experience in product marketing, business development, and partnership strategy, helping translate complex technologies into clear value propositions and actionable commercialization strategies.
Shane Kilpatrick is the Founder and former CEO of Membio, a high-growth Canadian biotech start-up that was acquired in 2024. With degrees in Biology (BSc), Chemical Engineering (MASc), and Business (MBET), he combines deep technical expertise with entrepreneurial vision. For many years, Membio focused on manufacturing fully functional red blood cells outside of the body for use in transfusion medicine, diagnostics, and therapeutics. The company strategically pivoted to commercializing the biomanufacturing technologies they developed for cost-effective at-scale manufacturing. Within 12 months they began generating revenue using an MVP product and were acquired by an industry leading company shortly thereafter.
David is a Business Lawyer and Principal at Crescendo Law. Crescendo Law is a business law firm serving entrepreneurs, business owners and investors in Toronto, Hamilton, and Southern Ontario. The firm delivers sophisticated business law advice in the following three practice areas: 1. Corporate Law, 2. Commercial Law, and 3. Corporate Finance.
Ken Kron is an accomplished molecular biologist and team leader with extensive experience in RNA therapeutics, gene editing, high-throughput screening, and next generation sequencing techniques. Most recently serving as Director of Biology at Deep Genomics, he led multidisciplinary teams in the development and validation of AI-informed RNA therapies, spanning antisense oligonucleotides, small RNAs, and RNA editing modalities. With a foundation in cancer epigenetics and transcriptional regulation research from his post-doctoral fellowship at the Princess Margaret Cancer Centre, Ken has consistently driven scientific innovation and cross-functional collaboration throughout his career. He has played a pivotal role in scaling experimental platforms, mentoring emerging scientists, and publishing impactful findings in top-tier journals such as Nature Genetics and Cancer Cell. Ken holds a PhD in Laboratory Medicine and Pathobiology from the University of Toronto, where he investigated prognostic DNA methylation events in prostate cancer, and a BSc in Molecular Biology and Genetics from the University of Guelph.
I am a highly entrepreneurial, strategic-minded and effective business development/partnering executive and consultant to the global pharmaceutical, biotechnology and medical device industries. I offer extensive experience licensing, acquiring and divesting companies, products and technologies in major markets throughout the world, including the U.S. and Canada, Europe and Asia.
My goal in working with McMaster-originated companies is to help founders i) determine the commercial value of their opportunity, and ii) develop and execute a meticulous and thorough strategic plan that will result in company success.
This will include mentoring and advising founders in the areas of:
If you believe I may be able to help you, please reach out. I look forward to hearing from you!
Andrew McDowall, P.Eng is a Executive Director with 17 years of expertise in KPMG’s Incentives practice, specializing in leveraging tax credits and direct funding support to foster innovation in businesses. A graduate of the Mechanical/Automotive Engineering program at the University of Windsor, Andrew began his career at the University of Windsor/DaimlerChrysler Automotive Research and Development Centre, where he contributed in the Automotive Structural Durability Lab for four years.
At KPMG, Andrew has consulted across diverse sectors, including IT, software, digital media, manufacturing, health tech, and engineering. His work involves helping companies identify the best sources of non-dilutive funding such as preparing Scientific Research & Experimental Development (SR&ED) claims, which enables him to swiftly assess the relevance of company activities to available tax credits and funding programs.
Andrew has participated in various government diligence projects. Notably, he has worked with Industry Canada (ISED) on government due diligence related to the Automotive Investment Fund, the Automotive Supplier Investment Fund, and the Advanced Manufacturing Fund, focusing on innovative technologies within the automotive sector. Additionally, he has partnered with organizations of all sizes to enhance the tracking and identification of R&D activities through improved internal cost tracking and document management systems.
Andrew’s commitment to advancing Canada’s innovation landscape is further reflected in his active participation in strategic consultations and public presentations, notably speaking at Collision and Web Summit Masterclasses since 2022.
Nabeela is a Principal at TELUS Global Ventures, where she invests in impact-first startups addressing challenges in agriculture, health and the environment. Nabeela cut her teeth in venture at Relay Ventures, where she focused on transformative fintech and AI solutions at the early stage.
As an advocate for women’s empowerment, she co-founded the Canadian Women in VC community and was an activator at Coralus (fka SheEO). Prior to joining the venture ecosystem, Nabeela had a short half-life as an Electro-Optics Engineer. Nabeela holds a B. Eng. in Engineering Physics from McMaster University. She is the recipient of Corporate Knights’ Top 30 Under 30 Sustainability Leaders (2022).
Marcia Mohammed is the founder of Social MD (@socialmdteam), where she helps businesses grow through digital marketing.
Before she started her company, Marcia spent over 18 years as a digital marketing and sales professional for companies like Yahoo, Bell, and Tor Star Media.
After a successful career helping corporate brands like BMO, Unilever, and Kimberly Clark, Marcia now focuses on partnering with small to medium-sized businesses where she shares her industry expertise and passion for marketing.
Alexander Morsink is a Co – Founder and Managing Director of Equivesto, a Canadian equity crowdfunding platform. In addition, Alexander is the Ultimate Designated Person and a Dealing Representative of Equivesto’s Exempt Market Dealer Subsidiary.
Before founding Equivesto, Alexander worked for several years at Scotiabank in both Corporate Banking and Commercial Banking, with some experience from Private Equity thrown in for good measure. Alexander has a Bachelor of Commerce from Smith School of Business at Queen’s University.
Alex is passionate about Canadian startups and small business. The ‘why’ behind Equivesto is all about improving access for both companies and investors to exciting opportunities, and changing the way businesses succeed. Alex understands the challenge of getting Angel or VC funding, with such a small percentage of companies raising capital that way, and knows that the success of your business shouldn’t depend on knowing the right people or looking a certain way. As part of his efforts to support Canadian entrepreneurs, Alex has presented at several Universities across Canada on this topic and is often a guest judge at pitch competitions across Canada including The CNE Emerging Innovators, Business in the Streets, and is a perennial feature of TorontoStarts events.
As one of the co-founders of Mabel’s Labels, Tricia has experienced everything on the spectrum from Idea to Acquisition. Mabel’s Labels is a direct-to-consumer custom printing company that started at $0 and was 100% bootstrapped with no investors or debt. While most manufacturing is done in-house, some off-shore production was outsourced to meet the demands of retailers such as Target and Walmart, for non-custom products. Mabel’s Labels was sold to Avery Products in 2016. Tricia was deeply involved in the acquisition process and lead the negotiations and presentations.
Tricia was the VP of Marketing & Product Development from 2002-2016 and focused on community building, digital selling, branding, and product design. When the business was successfully sold, Tricia took on the role of General Manager from 2016 – 2020.
For the past year, Tricia has been consulting with companies looking to increase their brand profile, create a solid marketing plan tied to powerful goals and find creative solutions to production issues. As an “ideas person”, Tricia has a lot of energy for entrepreneurs, their ideas, and making the most of every opportunity. “Let’s have some fun!”
Dr. Lee Nicholson is a product development and commercialization leader with 25 years of experience advancing complex technologies from research and prototype to real products, adoption, and scaled execution. He holds a Ph.D. in Materials Science and an M.Phil. in Physics from the University of Cambridge, UK.
His career has included aerospace research at NASA Langley, program leadership at IBM Microelectronics, innovation and technology-transfer work at PepsiCo Global R&D, and senior leadership roles in MedTech ventures. Across those settings, he has worked through many of the same challenges early innovators face: technical ambiguity, competing priorities, stakeholder alignment, and the path from concept to commercialization.
Lee has led 10 technology transfers and contributed to 5 industry-first commercializations. He co-invented and helped scale the world’s first 3D digital surgical loupes, later used in more than 1,800 surgeries, and helped deliver the first AI-enabled robotic stereoscopic 4K imaging systems into live surgical use. He is also an inventor on 27 issued U.S. patents, and his work has been recognized by IBM, PepsiCo, and Medical Device Network for innovation and execution.
Through mentoring and guest lecturing, Lee helps innovators sharpen the problem, clarify user and buyer needs, and make more credible next-step decisions. He is known for practical, thoughtful guidance and for helping innovators turn bold ideas into breakthrough products.
Andrew began his career in the tech and innovation ecosystem at SVB where he was one of the first 10 employees brought on to help build and expand SVB’s operations across Canada. As SVB continued to grow, Andrew moved into Relationship Management and has been focused on supporting, mentoring, and learning from early-stage founders ever since.
Andrew is now a VP on the RBCx Banking team, having joined in September 2023 to help build out its Early-Stage Banking practice. With a strong focus on connecting founders with capital and resources, in the last year Andrew has introduced dozens of founders to VCs and Angels across North America, two of which recently resulted in term sheet offerings.
As a Financial Services leader with 17+ years of strategy formulation and project execution across retail, corporate and institutional spaces; my experience covers enterprise transformation, digitalization, risk management frameworks including ESG and cybersecurity/technology risks. Over the last 10 years, I have taken executive level leadership assignments to establish and enhance infrastructure and first line of defence (FLOD) across corporate/commercial lines of businesses and geographies. Having worked with numerous international institutions and consulting firms, I have a globally connected mindset, exposure to different cultures and am used to working across different time zones and managing remote teams. My goal is to make the risk management frameworks more than just a control suite – I establish and lead these frameworks to be an enabler and infrastructure for healthy growth of the business/organization. I believe in data driven robust processes where all stakeholders agree upon, and informed decision making leveraging these processes to manage risks. I avoid a 0-risk approach and believe it is against the business objectives. I understand the strategic, business and operational perspectives well enough to implement a framework that will help re-invent the organization to progress to the next stage.
My strengths include entrepreneurial mindset, strategic thinking, deep knowledge of banking business processes, rational data driven approach, working with multifunctional teams across different regions, improving organizational effectiveness and strategic leadership.
As an Industrial Engineer, I hold an MBA in Banking and Finance, and I am a designated FRM (Financial Risk Manager), PMP (Project Management Professional), Change Management Practitioner (PROSCI, ADKAR methodology and Proxima) and Specialized in Materiality of ESG Factors and ESG Risk Management.
Ingrid is an immigrant originally from Brazil, and is a successful entrepreneur with more than 10 years in tech, and a mentor for startups across North, South and Central America.
Founder and ex-CEO of SafetyDocs Global, she focused on managing the development of client-centred solutions, optimizing efficiency and lowering operations costs worldwide. She Started her company in Brazil and expanded it internationally. Her company went thru prestigious acceleration programs: Google for Startups, The Accelerator Center and Latam Startups.
Ingrid’s experience as a founder allowed her to develop a lot of skills to mentor and advise founders globally. She has developed international projects in Brazil, Argentina, Chile, Mexico, the USA, Vietnam, Bermuda, Costa Rica, Jamaica, El Salvador and Canada.
In Canada, she is an active mentor in multiple innovation hubs, backing early-stage founders on their day-to-day challenges.
In her mission to support immigrant founders, she became the Co-chair of the Brazilian-Canadian Chamber of Commerce in British Columbia, fomenting trade between the two countries. As well as founding the Find A Way Podcast, spotlighting the story of immigrant entrepreneurs.
Scott Pundsack is a lawyer and patent agent with over 25 years of experience. Scott has been a partner at a boutique intellectual property law firm and at a full-service national law firm. He is currently Counsel at Smart & Biggar and fractional in-house patent counsel for two startups. Scott is active in patent procurement, dispute resolution and licensing. His work covers most aspects of chemical, mechanical and civil engineering with a focus on medical devices, drug delivery, bioreactors, nanoparticles, membranes, water treatment and building science. Scott is an active angel investor with the Golden Triangle Angel Network (GTAN) and Element 8 and a member of the McMaster Seed Fund investment committee.
Bruce works for ATS Automation, a Canadian company who is a world leader in automation. Through his current role in Applications Engineering, Bruce develops automation solutions for clients.n
Having industry experience in the automotive, aeronautical, consumer products, energy and life sciences sectors as a Mechanical Designer and Project Manager, he is excited to share his experience with entrepreneurs as they bring their ideas to life.
Carolynn Reid has spent the majority of her career supporting Hamilton’s small businesses. For the last 20 years, she was a Business Development Consultant with the City of Hamilton’s Economic Development Division having held several key leadership roles that have been of great benefit to the City of Hamilton, its citizens and businesses. Carolynn managed and established the first Small Business Enterprise Centre in the City. She built programs and developed partnerships that assisted hundreds of Hamilton small businesses get off the ground. Carolynn also managed the City’s brownfield portfolio in its very early years and laid the foundation for the redevelopment of hundreds of contaminated sites. For the last 10 years, Carolynn put her efforts into managing the emerging economic sectors of Life Sciences and Digital Media for the City, helping stimulate investment interest, supporting community programs and champions working together to build a better Hamilton.
Carolynn has always and continues to call Hamilton home. Born and raised in this great City, a McMaster University Commerce graduate and community builder to the core, she is excited to join the Forge mentorship team.
Maxim is an outbound growth marketer with over 5 years of experience in helping B2B SaaS startups achieve their revenue and growth goals. He works at LeadGen-Close, a premier outbound prospecting and sales conversion company that provides end-to-end lead generation solutions tailored to each client’s unique needs.
His core competencies include outbound sales, paid social media advertising, customer relationship management (CRM), and data-driven lead generation and sales conversion. Max uses innovative and proven outbound marketing strategies to attract, qualify, and convert prospects into customers. He also leverages data and analytics to optimize and improve the performance and ROI of each campaign. His mission is to help B2B SaaS startups grow their customer base and revenue with a custom-built sales funnel based on data, not hunches.
Cam has a diverse background in venture capital, finance, health tech, biotech, and AI/ML. Most recently, Cam was a Principal and Head of Ventures at Entrepreneur First, where he led a team of venture partners and coached first-time founders in customer hypothesis validation, market sizing, prototype development, and fundraising strategy. Prior to this, Cam was a Strategy & Investment Lead at Georgian, a venture capital firm, where he identified and invested in market leaders in core banking, applied AI, immersion tech, and cybersecurity. Cam has also held other leadership positions in the Canadian startup ecosystem including at Real Ventures, Front Row Ventures, and Creative Destruction Lab.
Experienced leader with a 20+ year track record of designing and executing go-to-market strategies for scalable growth across various technology sectors. Prior to joining MesoMat, Sam led go-to-market & strategic initiatives for Gatik, where as part of the Founding Team he helped drive Gatik’s meteoric growth – as the market leader in autonomous middle mile transportation – through multiple Fortune 500 client attraction and equity financing events. He was the Founding Director of the Innovation Factory’s Centre for Integrated Transportation and Mobility (CITM), a technology accelerator for CAV (Connected Autonomous Vehicle) technologies. Sam started his CAV journey at the Ontario Centres of Innovation where he managed a sizable innovation funding portfolio. Before entering the technology sector, Sam spent his earlier career focused on education, health promotion, and international development at the MaRS Discovery District, University of Toronto, and United Nations.
Over a decade in product management has honed my vision, drive, and dedication to creating standout digital solutions. With eleven years in the field, I’ve mastered the journey from ideation to delivery, always placing the customer at the heart of every decision. Agile methodologies and a strategic adoption of OKRs guide my approach, ensuring both alignment and measured outcomes. My experience has made me adept at crafting MVPs and wireframes that breathe life into innovative products aligned with market demands.
As a Product Manager, my leadership transcends beyond managing products; I mentor and inspire teams to push boundaries, always upholding a data-driven, user-centric approach. I leverage OKRs to align cross-functional teams with clear objectives, fostering collaboration, and driving impactful outcomes. I’m not just about delivering products; I’m about ensuring that they resonate, make an impact, and drive growth.
Amar is the founder of Amar-VR Law, a modern and mercurial law firm specializing in business and technology law. His aim is to utilize technology to provide innovative legal services that make navigating legal obstacles more accessible and affordable. Amar ensures his clients have an easy, convenient, and memorable experience.
As an entrepreneur himself, Amar understands that starting a new venture takes courage and is a trying task even without legal challenges. To ease the burden for entrepreneurs, he designed dedicated legal services that help build, protect, and grow start-ups and early-stage companies.
People-focused, experienced Dealmaker and Executive with a demonstrated history of working in the management consulting, banking and investment industry. Expert in Negotiation, Needs Analysis, Coaching, Corporate Development, and Leadership.
Passionate about building meaningful relationships with people and making beneficial introductions between people and companies. Every potential transaction starts with a conversation and comes to fruition through the development of relationships and mutually aligned interests. It is my objective to help facilitate this process.
Dr. Yasaman Soudagar received her PhD in 2012 from Ecole Polytechnique de Montreal, under the supervision of Dr. Nicolas Godbout (Polytechnique) and Dr. Aephraim Steinberg (University of Toronto), in the field of Experimental Quantum Optics. She then tenured her NSERC industrial postdoctoral scholarship at Attodyne. Soudagar was always interested in understanding how the brain works. An encounter with a neuroscientist made her realize the need for simultaneous multi-region imaging of the brain in the level of neurons. The encounter gave rise to the invention of the multi-region miniscopes and formation of Neurescence in 2015. In the ensuing 7 years, Neurescence had 2 products on the market and was generating revenue. The highly innovative nature of the Neurescence technology resulted into its acquisition by Bruker (NASDAQ: BRKR) in 2022, giving greater than 20X return to its early investor. Dr. Soudagar is currently the co-Founder/CEO of her second startup, Exhilarare, focused on advanced manufacturing. She is also an investor through Firehood Angels and is currently advising multiple startups in the Life Sciences and Medical Device space.
Suresh is a technology and business lawyer with a background in engineering and entrepreneurship. He completed his articles at boutique firms in the areas of corporate, technology and administrative law. Over the course of his professional career, Suresh has held executive roles with various organizations, launched three ventures and mentored dozens of startups. He has also worked for leading companies such as Amazon, Microsoft and BlackBerry. Suresh speaks English, French and Tamil.
Suresh has earned four prestigious degrees: Juris Doctor (JD) from Osgoode Hall Law School, Strategic Management (MBA) from Lazaridis School of Business & Economics, Electrical Engineering (BASc) and Liberal Studies (BA) from the University of Waterloo. He was the recipient of the Student Honours Award at Osgoode, CIBC Leaders in Entrepreneurship Award and John McBain International Award for humanitarian work. Suresh is a member in good standing of the Law Society of Ontario. He is an active mentor at various incubators and universities.
Randy brings 30+ years of enterprise B2B sales experience selling a variety of software solutions directly to customers. Randy has worked with many start-ups and large vendors (the likes of IBM, Sun Microsystems, Xerox, etc.). Currently, he consults with start-ups on their go-to-market efforts and develops the skills of the people doing the selling, creating a vision for customers and making sure the staff is executing well. Getting customers is fundamental to launching a company and it requires a lot of diverse skills. It is easy to get lost in the many activities large organizations ask of a vendor. Knowing how to scope your efforts and prioritize activities is key. Having done this successfully for several decades, it is great to be able to coach and mentor others in how to find, develop and close business with some of the largest companies in the world. This is the sweet spot in Randy’s skill set and the focus of his consulting company.
Ben Su (H.B.Sc.; J.D.) is a lawyer and co-founder of Capita, which is building the world’s first AI lawyer for startups, backed by leading venture capital firms, including Drive Capital, Hyperplane VC, and Fresh Founders.
Dr. Alison Symington provides consultancy services to a variety of industry, academic and government clients in the area of life science strategy particularly in the development of new technologies with a focus on accessing non-dilutive funding. These services include large network applications directly to government or industry bodies as well as industry and or research proposals for funding. Clients have included large academic institutions, not for profit innovation hubs, government, foundations, and SMEs both in Canada and internationally. Alison works across multiple sectors including healthcare, agriculture, natural resources, and the environment. She also provides expert reviews to a variety of government funding agencies on funding allocations. Before starting her own consultancy business, Alison was the Vice President, Research and Corporate Development at Ontario Genomics. In this role, she was responsible for the development and management of large-scale research projects as well as external stakeholder engagement, including government relations. Alison was a Professor at Seneca where she also coordinated the post-graduate Regulatory and Quality Assurance program. Before joining Seneca College, she was the Manager of Viral Development Laboratory and a research scientist at Sanofi Pasteur for almost 10 years, where she led several new viral vaccine development processes from bench to clinical trials. She received her Ph.D. in molecular and cell biology in 1991. In addition to these activities, Alison is currently the Chair of the Board of Life Sciences Ontario and a Board Member of the Science and Technology Awareness Network, a not for profit focused on science outreach.
Karen is a customer-centric fractional CMO for SaaS and telemedicine startups. She fixes growth challenges by putting the customer at the core of all business decisions and by helping founders and their teams draw customers in vs pushing the product out to drive revenue. The types of issues she fixes include product development challenges and working towards product-market fit, an unclear vision or brand strategy that isn’t resonating with customers, a lack of brand awareness that is hampering leads and sales, inefficient business processes, hiring the wrong team, or simply not having a strategic business plan in place.
She helps clients solve these problems by designing strategies, processes and tactics focused on the customer which she believes is the secret to business growth. Her clients are pre-revenue up to ARR of $10MM. Karen’s expertise includes business strategy, brand, marketing, product management and operations.
Her diverse industry background which includes technology (SaaS), telemedicine, financial services, gaming/entertainment, photography, government, consumer electronics, and digital media was honed over a 30-year career working for brands such as Fujifilm, OLG, Rogers, Intuit, Microsoft and many others. She now works exclusively with startups, following her passion to give back to the tech community to support innovation and help founders with breakthrough ideas.
Noel Webb is an accomplished entrepreneur and investor driving innovation in technology and AI. As Founder and Managing Partner of Lucid Ventures, he fuels growth in early-stage tech startups through strategic investments and hands-on leadership.
Noel founded Karen AI, an AI-powered recruiting assistant leveraging natural language processing, later acquired by AMS. He also built CTrade Inc., an algorithmic cryptocurrency trading platform, and honed his investment expertise as Entrepreneur-in-Residence at Whitecap Venture Partners, assessing high-potential ventures.
As Global Head of Digital Products at AMS, Noel led digital partnerships and innovation. He has advised transformative companies like Maneva.ai, Eye3 Concepts, and Cybrid, and mentors AI-native startups at NEXT Canada and Creative Destruction Lab, fostering bold entrepreneurship.
David Zak is a Canadian entrepreneur with over 17 years of experience in creativity, marketing, sales, and product development. As founder of ArtResin, he identified a market need for safe, non-toxic epoxy resin and partnered with chemists to create a revolutionary product, growing the brand to $20M+ in annual revenue and expanding globally across North America, Europe, Asia, and Australia.
A natural problem-solver and innovator, David excels in brand development, market research, and product commercialization, with a strong focus on creative design and user experience. Beyond ArtResin, he has successfully launched diverse product lines for industrial and craft markets, driven by strategic planning and data-driven decision-making.
Now, David leverages his expertise to empower fellow entrepreneurs, helping them turn their visions into reality.